Mortality of major cancers in Guangxi, China: Sex, age and geographical differences from 1971 and 2005

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 4, 2014, Pages 1567-1574

  Deng, Wei ^a   Long, Long ^a   Li, Ji Lin ^a   Zheng, Dan ^a   Yu, Jia Hua ^a   Zhang, Chun Yan ^a   Li, Ke Zhi ^a   Liu, Hai Zhou ^a   Huang, Tian Ren ^a  

^a GUANGXI TEACHERS EDUCATION UNIVERSITY   (China)

Author keywords

1971 2005; Cancer; China; Guangxi; Mortality

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHINA; FEMALE; GEOGRAPHY; HUMAN; MALE; MIDDLE AGED; MORTALITY; NEOPLASM; SEX RATIO; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHINA; FEMALE; GEOGRAPHY; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; SEX DISTRIBUTION; YOUNG ADULT;

EID: 84896972448     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.4.1567     Document Type: Article

References (37)

1. Anderson BO, Yip CH, Smith RA, et al (2008). Guideline implementation for breast healthcare in low-income and middle-income countries. Cancer, 113, 2221-43.
2. Atkin WS, Edwards R, Kralj-Hans I, et al (2010). Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet, 375, 1624-33.
3. Center MM, Jemal A, Ward E. (2009). International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev, 18, 1688-94.
4. Centers for Disease Control and Prevention (2007). Best Practices for Comprehensive Tobacco Control Programs. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
5. Chang MH. (2014). Prevention of Hepatitis B Virus Infection and Liver Cancer. in: Viruses and Human Cancer, Springer, pp. 75-95.
6. Cho E, Kang MH, Choi S, et al (2013). Cost-effectiveness of Korea's national cervical cancer screening program. Asian Pac J Cancer Prev, 14, 4329-34.
7. Colditz GA, Sellers TA, Trapido E. (2005). Epidemiology-identifying the causes and preventability of cancer? Nat Rev, 6, 75-83.
8. Cucchetti A, Cescon M, Erroi V, Pinna AD. (2013). Cost-effectiveness of liver cancer screening. Best Pract Res Clin Gastroenterol, 27, 961-72.
9. de Groot P, Munden RF. (2012). Lung cancer epidemiology, risk factors, and prevention. Radiol Clin North Am, 50, 863-76.
10. Dong ZW, Qiao YL, Li LD, et al. (2009). A report of cancer high incidence scene in China. China Cancer, 1, 4-9.
11. Dong ZW(2002). Prevention and treatment for cancer, a longlasting approach. China Cancer, 11, 2-3.
12. Fan1 J-H, Wang J-B, Jiang Y, et al (2013). Attributable causes of liver cancer mortality and incidence in China. Asian Pac J Cancer Prev, 14, 7251-56.
13. Ferlay J, Bray F, Pisani P, Parkin D. (2007). GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5. version 2.0, IARCPress, Lyon, 2004. Valero-Malaria in Colombia, 195.
14. Ferrari P, Jenab M, Norat T, et al (2007). Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer, 121, 2065-72.
15. García-álvarez A, Serra-Majem L, Ribas-Barba L, et al (2007). Obesity and overweight trends in Catalonia, Spain (1992-2003): gender and socio-economic determinants. Public Health Nutr, 10, 1368-78.
16. Gwack J, Park SK, Lee E-H, et al (2011). Hepatitis B vaccination and liver cancer mortality reduction in Korean children and adolescents. Asian Pac J Cancer Prev, 12 2205-8.
17. He J, Chen WQ (2010). Annual Report of Cancer Registration in China. Beijing: Military Medical Science Press 2012, 10.
18. Hulka BS, Moorman PG. (2008). Reprint of Breast cancer: hormones and other risk factors. Maturitas, 61, 203-13.
19. Ito K, Tsunematsu M, Satoh K, et al (2013). Effectiveness of cervical cancer screening based on a mathematical screening model using data from the Hiroshima Prefecture Cancer Registry. Asian Pac J Cancer Prev, 14, 4897-902.
20. Kushi LH, Byers T, Doyle C, et al (2006). American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin, 56, 254-81.
21. Mandel JS, Bond JH, Church TR, et al (1993). Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med, 328, 1365-71.
22. Ming L, Thorgeirsson SS, Gail MH, et al (2002). Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology, 36, 1214-20.
23. Moore MA. (2013). Overview of cancer registration research in the Asian Pacific from 2008-2013. Asian Pac J Cancer Prev, 14, 4461-84.
24. Okamoto E. (2013). Cohort analysis of incidence/mortality of liver cancer in japan through logistic curve fitting. Asian Pac J Cancer Prev, 14, 5891-93.
25. Zheng RS, Zhang SW, Wu LY, et al (2012). Report of incidence and mortality from china cancer registries in 2008. China Cancer, 1, 1-12.
26. Sankaranarayanan R, Nene BM, Shastri SS, et al (2009). HPV screening for cervical cancer in rural India. N Engl J Med, 360, 1385-94.
27. Sherris J, Wittet S, Kleine A, et al (2009). Evidence-based, alternative cervical cancer screening approaches in low-resource settings. Int Perspect Sex Reprod Health, 35, 147-52.
28. Spitz M, Wu X, Wilkinson A, et al (2006). Cancer of the lung. Cancer Epidemiol Prev, 3, 638-58.
29. Thun MJ, Hannan LM, Adams-Campbell LL, et al (2008). Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med, 5, e185.
30. Turner P, Sylla A, Gong Y, et al (2005). Reduction in exposure to carcinogenic aflatoxins by postharvest intervention measures in west Africa: a community-based intervention study. Lancet, 365, 1950-56.
31. World Health Organization (2009). WHO Vaccine-Preventable Diseases: Monitoring System: 2009 Global Summary.
32. World Health Organization (2010). Framework Convention On Tobacco Control. 2003. Geneva, Switzerland.
33. Yao H, Shi L. (2003). Meta-analysis of the risk factors on lung cancer in Chinese people. Chinese J Epidemiology, 24, 45-9.
34. Yeo Y, Gwack J, Kang S, et al (2013). Viral hepatitis and liver cancer in Korea: an epidemiological perspective. Asian Pacific J Cancer Prev, 14, 6227-31.
35. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, et al (2008). Evaluating test strategies for colorectal cancer screening: a decision analysis for the US Preventive Services Task Force. Ann Intern Med, 149, 659-69.
36. Zhao P, Kong LZ (2010). Cancer death report-the third retrospective sampling survey of death causes, China. First edition, Beijing: People's medical publishing house.
37. Zhu YR (2012). Research progress in prevention of major risk factors of liver cancer in Qidong. China Cancer, 21,759-62.